News
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...
3d
Lose It! on MSNWhat to Track in Lose It! if You’re Taking a GLP-1 DrugThere’s a lot to remember when taking a GLP-1 medication. Here are 5 ways to use the Lose It! app to help optimize your ...
This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP) ...
Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...
Ōura, maker of a health-monitoring smart ring, announced that it will use AI to track and analyze two new metabolic health features: meals and glucose.
The studies were postmarketing requirements the FDA requested in 2013 of all companies with new opioid analgesics for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results